These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 20685314)

  • 41. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes.
    Haid S; Novodomská A; Gentzsch J; Grethe C; Geuenich S; Bankwitz D; Chhatwal P; Jannack B; Hennebelle T; Bailleul F; Keppler OT; Poenisch M; Bartenschlager R; Hernandez C; Lemasson M; Rosenberg AR; Wong-Staal F; Davioud-Charvet E; Pietschmann T
    Gastroenterology; 2012 Jul; 143(1):213-22.e5. PubMed ID: 22465429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system.
    Das S; Shetty RK; Kumar A; Shridharan RN; Tatineni R; Chi G; Mukherjee A; Das S; Subbarao SM; Karande AA
    PLoS One; 2013; 8(1):e53619. PubMed ID: 23341957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus.
    Yang W; Qiu C; Biswas N; Jin J; Watkins SC; Montelaro RC; Coyne CB; Wang T
    J Biol Chem; 2008 Mar; 283(13):8643-53. PubMed ID: 18211898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Anti-hepatitis C virus strategy targeting host entry factor claudin-1].
    Fukasawa M
    Uirusu; 2015; 65(2):245-254. PubMed ID: 27760923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.
    Padmanabhan P; Dixit NM
    PLoS One; 2012; 7(4):e36107. PubMed ID: 22545157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission.
    Tarr AW; Lafaye P; Meredith L; Damier-Piolle L; Urbanowicz RA; Meola A; Jestin JL; Brown RJ; McKeating JA; Rey FA; Ball JK; Krey T
    Hepatology; 2013 Sep; 58(3):932-9. PubMed ID: 23553604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors.
    Syder AJ; Lee H; Zeisel MB; Grove J; Soulier E; Macdonald J; Chow S; Chang J; Baumert TF; McKeating JA; McKelvy J; Wong-Staal F
    J Hepatol; 2011 Jan; 54(1):48-55. PubMed ID: 20932595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation.
    Fafi-Kremer S; Fofana I; Soulier E; Carolla P; Meuleman P; Leroux-Roels G; Patel AH; Cosset FL; Pessaux P; Doffoël M; Wolf P; Stoll-Keller F; Baumert TF
    J Exp Med; 2010 Aug; 207(9):2019-31. PubMed ID: 20713596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of an effective single-chain variable fragment recognizing a novel epitope in the hepatitis C virus E2 protein that restricts virus entry into hepatocytes.
    Das S; Behera P; Shewale DJ; Bodele J; Das S; Karande AA
    Arch Virol; 2024 Apr; 169(5):112. PubMed ID: 38683226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Claudin 1 as a target for anti-hepatitis C virus strategy].
    Fukasawa M
    Yakugaku Zasshi; 2014; 134(5):635-40. PubMed ID: 24790046
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
    Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L
    PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Anti-hepatitis C Virus Strategy Targeting the Entry Steps].
    Fukasawa M
    Yakugaku Zasshi; 2019; 139(1):89-95. PubMed ID: 30606936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes.
    Qian XJ; Zhang XL; Zhao P; Jin YS; Chen HS; Xu QQ; Ren H; Zhu SY; Tang HL; Zhu YZ; Qi ZT
    Sci Rep; 2016 Jun; 6():27268. PubMed ID: 27252043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.
    Keck ZY; Li SH; Xia J; von Hahn T; Balfe P; McKeating JA; Witteveldt J; Patel AH; Alter H; Rice CM; Foung SK
    J Virol; 2009 Jun; 83(12):6149-60. PubMed ID: 19321602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
    Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
    J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein.
    Hung TC; Jassey A; Liu CH; Lin CJ; Lin CC; Wong SH; Wang JY; Yen MH; Lin LT
    Phytomedicine; 2019 Feb; 53():62-69. PubMed ID: 30668413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.
    Liu S; McCormick KD; Zhao W; Zhao T; Fan D; Wang T
    Hepatology; 2012 Aug; 56(2):484-91. PubMed ID: 22334503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Curcumin against hepatitis C virus infection: spicing up antiviral therapies with 'nutraceuticals'?
    Pécheur EI
    Gut; 2014 Jul; 63(7):1035-7. PubMed ID: 24092864
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.
    Schwarz AK; Grove J; Hu K; Mee CJ; Balfe P; McKeating JA
    J Virol; 2009 Dec; 83(23):12407-14. PubMed ID: 19776133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.
    Zheng A; Yuan F; Li Y; Zhu F; Hou P; Li J; Song X; Ding M; Deng H
    J Virol; 2007 Nov; 81(22):12465-71. PubMed ID: 17804490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.